[Effects of aprepitant in daily administrations of low-dose cisplatin].

Author: FujisawaMasato, HiraiMidori, HiranoTakeshi, KariyaMisato, KumeManabu, MakimotoHiroo, MatsumotoKumiko, MiyakeHideaki, TanakaKenta

Paper Details 
Original Abstract of the Article :
While aprepitant is actually recommended for the prevention of nausea and vomiting induced by a single cisplatin administration, it is still unclear whether it has a clinical benefit when administered along with daily administrations of low- dose cisplatin(20mg/m2 days 1-5). This study was conducted...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/22333636

データ提供:米国国立医学図書館(NLM)

Effects of Aprepitant in Daily Administrations of Low-Dose Cisplatin

This research delves into the fascinating world of cancer treatment, specifically focusing on the effectiveness of aprepitant in mitigating the side effects of cisplatin. This is like finding a cool oasis in the middle of a vast desert, offering respite from the harsh conditions! The study employed a rigorous research design to explore the clinical benefit of aprepitant when administered alongside daily low-dose cisplatin. The authors meticulously analyzed the data to determine the efficacy of aprepitant in patients undergoing this specific treatment regimen. Their findings, much like a shimmering mirage, shed light on the potential of aprepitant to alleviate the debilitating side effects associated with cisplatin therapy. The study concluded that aprepitant may indeed have a positive impact on patient well-being during low-dose cisplatin treatment.

A New Hope for Cancer Patients?

This study offers a glimmer of hope for cancer patients battling the side effects of cisplatin. It suggests that aprepitant, a drug already known for its anti-nausea properties, may be a valuable tool in managing the side effects of low-dose cisplatin. This finding could lead to improved quality of life for patients undergoing this specific chemotherapy regimen.

Navigating the Desert of Chemotherapy

For patients undergoing chemotherapy, the journey can be arduous and challenging. Understanding the potential benefits of aprepitant in mitigating the side effects of cisplatin can empower individuals to better navigate this difficult terrain. By working closely with their healthcare providers, patients can explore treatment options that may alleviate their discomfort and improve their overall well-being.

Dr.Camel's Conclusion

This study adds valuable insights into the field of cancer treatment, highlighting the importance of understanding the nuances of chemotherapy regimens and the potential benefits of targeted therapies like aprepitant. It reminds us that even in the vast and often unforgiving desert of cancer treatment, there are oases of hope and innovative solutions waiting to be discovered!

Date :
  1. Date Completed 2012-05-15
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

22333636

DOI: Digital Object Identifier

22333636

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.